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ABSTRACT 
BACKGROUND AND OBJECTIVES: Young adults receiving kidney replacement therapy have impaired 
quality of life and may exhibit low medication adherence. We tested the hypothesis that wellbeing 
and medication adherence are associated with psychosocial factors. 
DESIGN, SETTING, PARTICIPANTS AND MEASUREMENTS: We conducted a cross-sectional online 
survey for young adults on KRT. Additional clinical information was obtained from the United 
Kingdom Renal Registry. We compared outcomes by treatment modality using age and sex adjusted 
regression models, having applied survey weights to account for response bias by gender, ethnicity 
and socio-economic status. We used multivariable linear regression to examine psychosocial 
associations with scores on the Warwick-Edinburgh Mental Wellbeing Scale and the 8-item Morisky 
Medication Adherence Scale. 
RESULTS: We recruited 976 young adults and 64% responded to the survey - 417 (71%) with 
transplants and 173 (29%) on dialysis. Wellbeing was positively associated with extraversion, 
openness, independence, and social support, and negatively associated with neuroticism, negative 
body image, stigma, psychological morbidity, and dialysis. Higher medication adherence was 
associated with living with parents, conscientiousness, physician access satisfaction, patient 
activation, age, and male sex, and lower adherence with comorbidity, dialysis, education, ethnicity 
and psychological morbidity.  
CONCLUSIONS: Wellbeing and medication adherence were both associated with psychological 
morbidity in young adults. Dialysis treatment is associated with poorer wellbeing and medication 
adherence.  
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INTRODUCTION 
End-stage kidney disease affects the psychosocial health of young adults aged 16-30 years receiving 
kidney replacement therapy (KRT). A recent systematic review demonstrated lower quality of life 
(QOL) compared to the general population, particularly for patients on dialysis(1, 2). We have 
previously reported that young adults on KRT have lower mental wellbeing and were twice as likely 
to have psychological morbidity (defined by a 12-item General Health Questionnaire (GHQ-12) score 
≥4) compared to the age and sex matched general population, again more pronounced for patients 
on dialysis(2). However, the determinants of wellbeing have not been established in this population. 
A qualitative synthesis exploring young adults’ perspectives on living with kidney failure described 
overall themes of uncertainty and liminality, difference and the desire for normality, and thwarted 
or moderated dreams and ambitions. Key underlying themes included physical appearance/body 
image and social isolation(3). 
The Society for Adolescent Health and Medicine’s position statement on young adults’ health and 
wellbeing says “Young adulthood is a unique and critical time of development where unmet health 
needs and health disparities are high. Purposeful prevention and intervention strategies should be 
developed, researched, and implemented during this time to improve health and wellbeing of young 
adults”(4). Needing KRT during young adulthood may have lasting consequences for later life. 
Medication non-adherence is common amongst kidney transplanted adolescents, estimated at 43% 
in a systematic review(5). Adults with chronic kidney disease (CKD) and poor adherence are more 
likely to have progressive disease(6), graft loss and death(7). Young adults are the highest risk age-
group for kidney transplant loss(8, 9). Medication non-adherence was estimated to account for 32% 
of kidney transplant loss in this group(5). Psychosocial wellbeing is a priority for patients and may 
provide insights into perceived poor engagement with healthcare services and medication 
adherence.  
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We have tested the hypothesis that wellbeing and medication adherence are associated with 
psychosocial factors using data from the ‘SPEAK’ (Surveying Patients Experiencing young Adult 
Kidney failure) study, a national cross-sectional survey of UK 16 to 30-year olds receiving KRT. We 
aimed to establish protective and risk factors to aid identification of high-risk sub-groups and 
potential interventions. 
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MATERIALS AND METHODS 
We designed a cross-sectional online self-completion survey for 16 to 30-year olds receiving KRT in 
the UK, after an initial pilot. The survey comprised questions (in English) from validated health 
surveys (reported elsewhere(2)) with comparable normative data. Additional scales and tools 
covering aspects of chronic disease were also included (described in supplementary table 1). The 
study was granted ethical approval by the Health Research Authority National Research Ethics 
Service Committee, reference 15/SW/0101. 
Clinical subjects 
The study inclusion criteria were 1) aged ≥16 years and <31 years and 2) receiving maintenance KRT. 
We chose a wide age range as there is no consensus definition of young adulthood. Subjects were 
excluded if participation was expected to cause psychological distress or they were unable to 
complete the questionnaire with assistance. Subjects were identified and approached for 
participation by the hospital providing their KRT. All National Health Service trusts with an adult or 
pediatric kidney unit (n=74) took part in the study, yet two did not recruit any participants. Sites 
opened sequentially and recruited for six months, between 2015 and 2017. We aimed to recruit 
1000 young adults and estimated a 50% response rate. Assuming equal group sizes, this provided 
90% power to detect a standardized difference (z-score) of 0.29 (α=0.05) and a 10% proportion 
difference for an outcome with a 10-50% prevalence. 
Participants selected survey access by email, or via a computer at their kidney unit (where available). 
Participants could be supported in survey completion as required. If no survey response was 
received, e-mail reminders were sent at 7 days, and at 14 days the kidney unit checked survey 
receipt and provided another reminder. We requested screening logs from sites to assess reasons 
for study non-participation. 
Survey software 
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Study data were collected and managed using Research Electronic Data Capture (REDCap) hosted at 
the University of Bristol(10). REDCap is a secure, web-based application designed to support data 
capture for research studies. It provided greater convenience to our participants than a paper survey 
by allowing a ‘save and return’ option and through use of branching logic to deliver relevant 
questions based on preceding filter responses, thereby reducing the burden of survey completion. 
Further, it avoided printing, postage and data entry costs and potentially reduced the risk of 
introducing data entry errors. 
Clinical data from the UK Renal Registry (UKRR) 
The UKRR collects data on all KRT patients from UK adult and pediatric kidney units(11, 12). It has 
been granted a section 251 exemption by the Health Research Authority, allowing the registration of 
identifiable patient information from kidney units without first asking individual patient consent. All 
participants were asked for consent to access their UKRR data regardless of survey response. We 
also accessed anonymized aggregate level data for study non-participants (those eligible for the 
SPEAK study as of December 2015, but who did not give consent), to enable comparison to the wider 
young adult population. This allowed examination and adjustment for response bias and description 
of clinical aspects for young adults receiving KRT. We classified primary kidney disease using a recent 
European coding system(13). 
Survey response 
We weighted survey responses as the inverse of the sampling fraction for gender, ethnicity and 
socio-economic deprivation, to account for survey response bias and thus be representative of the 
wider young adult KRT population.  
Statistical analysis 
We compared scale results by clinical characteristics (sex, treatment modality, pediatric/adult 
starting unit and duration) using age and sex adjusted regression models, appropriate to the data 
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and distribution. We followed scale author recommendation or published methods for handling 
missing data, using average or lowest score substitution. We developed theoretical frameworks to 
examine associations of selected outcomes. We used the Wilson and Cleary QOL model adapted by 
Ferrans et al(14) (supplementary figure 1), because this includes additional dimensions to explain 
QOL better(15). We chose the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) as the 
outcome variable in this model over EQ-5D-3L as it is less driven by physical aspects. For medication 
adherence, we used the 8-item Morisky Medication Adherence Scale (MMAS-8) and devised our 
own framework (supplementary figure 2) as we could find no precedent in the literature. In each 
framework we examined the explanatory variables (shaded variables in supplementary figures 1 and 
2) in turn to establish whether they were associated in an age and sex adjusted regression model. 
We combined shortlisted variables in a multivariable linear (least squares) regression model, 
adjusting for confounders. We removed non-associated explanatory variables from the final model, 
having checked that this did not affect the beta coefficients of the remaining variables. We checked 
for assumptions of linearity between continuous variables and the outcome variable, evidence of 
heteroscedasticity and that residuals were normally distributed with a mean of zero. We also tested 
for potential pre-specified interactions in our theoretical frameworks. We used Stata® 14 for our 
analyses. 
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RESULTS 
Survey response 
Figure 1 displays a study flowchart. Overall, 976 participants were recruited. The main reasons for 
study non-participation (data available from 48 sites) were 1) no response to the invitation letter 
(14%); 2) participation declined (9%) and 3) the subject could not be contacted (6%). The survey 
response rate was 64% (625/976) and has been described previously(2). There were 2,072 young 
adults known to the UKRR who did not participate, so our sample comprises 21% of the total eligible 
population. Characteristics of responders are shown in table 1. Responders were statistically more 
likely to be female, Caucasian, and have higher socio-economic status, compared to both survey 
non-responders and study non-participants. Compared to both survey non-responders and study 
non-participants, survey responders were more likely to be managed in smaller centers that do not 
undertake kidney transplantation. Survey responders with transplants had a slightly lower estimated 
glomerular filtration rate (eGFR) (-3.2 mls/min/1.73m2, 95% confidence interval (CI) -5.9, -0.5, 
p=0.02) than non-responders and non-participants, although this is of uncertain significance. There 
were no other differences. The median time to complete the survey was 53 minutes (interquartile 
range 40, 71) and most (595/625, 95%) selected survey access by email. 
Cohort characteristics 
The cohort comprised 417 (71%) patients with transplants and 173 (29%) on dialysis, and has been 
previously described(2). Survey participants were 51% male, 74% Caucasian, with a median age of 25 
years. The most common primary kidney disease group was ‘tubulointerstitial diseases’ (31%) due to 
structural causes, followed by ‘glomerular diseases’ (27%). The median duration since KRT start was 
6 years. The majority (59%) started KRT in adult services. Most were transplanted (71%), and the 
mean eGFR was 59 mls/min/1.73m2 (standard deviation (SD) 23). Few young adults were using 
peritoneal dialysis (6%, compared to 24% using hemodialysis). A fifth started KRT <90 days from first 
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nephrology review. Around 80% had undergone transplantation, with 27% having experienced 
transplant failure. 
Quality of Life, wellbeing, psychological morbidity, medication adherence and other scales 
Average scale scores are shown in table 2 (higher scores indicate better outcome unless stated 
below). The median EQ-5D tariff was 0.80 (interquartile range (IQR) 0.62, 1.00; possible range -0.59, 
1.00). From the GHQ-12, overall 43% had no evidence of mental health problems, 26% had below 
optimal mental health and 31% had probable psychological disturbance/mental ill health. The 
median Independence with Activities of Daily Living score was 26 (IQR 21, 27; possible range 9, 27). 
Medication adherence was low in 43%, medium in 34% and high in 23%. The median Body Image 
Scale score was 9 (IQR 3, 18; possible range 0, 30 - higher scores indicate worse body image). The 
median Social Impact Scale score was 40 (IQR 28, 53; possible range 21, 90 - higher scores indicate 
greater stigma). The median Multidimensional Scale of Perceived Social Support scale score was 65 
(IQR 54, 75; possible range 12, 84). On average, patient satisfaction was scored as 4 (possible range 
1, 5) across seven domains. The mean wellbeing score was 47.4 (SD 11.5; possible range 14, 70). 
There was good illness acceptance in 34%, moderate acceptance in 49%, and no acceptance in 17%.  
Patient activation was level 1 (may not yet believe that the patient role is important) in 26%, level 2 
(lacks confidence and knowledge to take action) in 18%, level 3 (beginning to take action) in 36% and 
level 4 (has difficulty maintaining behaviors over time) in 20%.  
Scale results by treatment modality  
Compared to transplant, young adults on dialysis had lower QOL (OR for EQ-5D ‘No problems’ 0.31; 
95% CI 0.19, 0.51; p<0.001), wellbeing (β -5.61; 95% CI -7.92, -3.29; p<0.001), disease acceptance (β -
5.35; 95% CI -6.78, -3.91; p<0.001) and patient activation (β -4.52; 95% CI -6.94, -2.10; p<0.001) 
(table 3). They were more likely to have worse psychological health (GHQ-12 group odds ratio (OR) 
1.9; 95% CI 1.2, 3.0; p=0.005), body image (above median score OR 1.7; 95% CI 1.1, 2.8; p=0.02), 
independence (below median score OR 0.3; 95% CI 0.2, 0.5; p<0.001) and stigma (above median 
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score OR 2.5; 95% CI 1.6, 3.9; p<0.001). Generally, young adults on dialysis were less satisfied, apart 
from ‘Interpersonal Manner’ and ‘Financial Aspects’ domains and these associations were unlikely to 
be due to chance. There was no difference in social support by treatment modality (OR 0.9; 95% CI 
0.61, 1.34; p=0.6). Compared to transplant, young adults on dialysis had lower medication 
adherence (MMAS group OR 0.4; 95% CI 0.2, 0.6; p<0.001). Supplementary table 1 details further 
comparisons by gender, pediatric or adult starting unit and duration. There were few differences by 
start or duration although young adults who started KRT in childhood had higher disease acceptance 
and a slightly higher patient activation score. 
Factors associated with wellbeing 
The greatest association with lower wellbeing was psychological morbidity (β -7.1; 95% CI -8.8, -5.4; 
p<0.001) (figure 2). Dialysis was also associated with lower wellbeing (β -1.8; 95% CI -3.2, -0.3; 
p=0.02) though we observed an attenuated effect from the crude differences (table 3) after 
adjustment in the multivariable model. Other negative associations included neuroticism (β -2.8; 
95% CI -3.9, -1.8; p<0.001), negative body image (β -1.3; 95% CI -2.4, -0.3; p=0.01) and stigma (β -2.1; 
95% CI -3.3, -0.8; p=0.001). In contrast, positive associations with wellbeing were: extraversion (β 
2.2; 95% CI 1.2, 3.2; p<0.001) or openness (β 1.9; 95% CI 0.7, 3.1; p=0.002), independence with 
activities of daily living (β 2.8; 95% CI 1.4, 4.3; p<0.001), and higher social support (β 2.5; 95% CI 1.0, 
3.9; p=0.001). Gender (β -1.2; 95% CI -2.6, 0.2; p=0.1) and age group (p=0.6 for trend) did not affect 
wellbeing when adjusted for other factors. Our final wellbeing model had an adjusted R2 value of 
68% suggesting reasonable model fit. We found no evidence for interaction between: GHQ-12 score 
and neuroticism, dialysis treatment or Independence with activities of daily living score; social 
support and extraversion or neuroticism; dialysis treatment and employment status. Univariable 
coefficients are shown in supplementary table 3. 
Factors associated with medication adherence 
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Factors lowering medication adherence (figure 3) comprised: having an additional condition (β -0.4; 
95% CI -0.7, -0.1; p=0.02), a lower age of finishing full-time education (p=0.01 for trend), Black and 
Asian ethnicities (β -1.5; 95% CI -2.4, -0.6; p=0.002, β -0.7; 95% CI -1.2, -0.1; p=0.02 respectively) and 
psychological morbidity (β -0.7; 95% CI -1.1, -0.4; p<0.001). Dialysis was also negatively associated, 
and the association was lessened from the crude difference (β -1.1; 95% CI -1.5, -0.8; p<0.001) after 
adjustment in the multivariable model (β -0.6; 95% CI -0.7, -0.1; p<0.001). 
In contrast, factors associated with a higher medication adherence score were: living with parents (β 
0.4; 95% CI 0.1, 0.8; p=0.01), conscientiousness (β 0.7; 95% CI 0.4, 0.9; p<0.001), greater physician 
access satisfaction (β 0.3; 95% CI 0.1, 0.5; p=0.008), higher patient activation (p=0.008 for trend), 
male gender (β 0.3; 95% CI 0.02, 0.6; p=0.04) and being aged 16 to <21 years (β 0.5; 95% CI 0.02, 1.0; 
p=0.04). There was no change in the dialysis coefficient after adjustment for psychological morbidity 
and/or patient activation (data not shown), suggesting these do not mediate the dialysis treatment 
effect. 
There was a significant interaction (likelihood ratio test p=0.002 between full model and model 
fitting the interaction term) between ethnicity and dialysis treatment. The stratum-specific exposure 
effects of ethnicity and dialysis (compared to White, dialysis) are as follows: Asian, Dialysis: β -1.19 
(95% CI -2.21, -0.16), p=0.02; Black, Dialysis: β -2.82 (95% CI -4.02, -1.62), p<0.001; Mixed/Other, 
Dialysis: β 0.60 (95% CI -1.20, 2.40), p=0.5; White, Transplant: β 0.50 (95% CI 0.14, 0.86), p=0.006; 
Asian, Transplant: β 0.02 (95% CI -0.69, 0.73), p=0.96; Black, Transplant: β 0.83 (95% CI -0.58, 2.24), 
p=0.2; Mixed/Other, Transplant: β -0.12 (95% CI -1.20, 0.95), p=0.8. There was no interaction 
between: living with parents and age at finishing full-time education or dialysis treatment; patient 
activation and conscientiousness or age at finishing full-time education; dialysis treatment and GHQ-
12 score. Univariable coefficients are shown in supplementary table 4. 
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DISCUSSION 
In young adults on KRT, worse outcomes for mental wellbeing and medication adherence were both 
associated with psychological morbidity and dialysis treatment, whilst social support and living with 
parents were associated with better outcomes. These findings are important because psychological 
disturbances may be treatable and should prompt caregivers to evaluate psychological state 
carefully as well as barriers to transplantation. Further, there is large potential for health and 
healthcare improvements for young adults due to the longer life expectancy compared to older 
adults on KRT. Psychological problems may be under-recognized; using the GHQ-12 as a screening 
tool, 31% of young adults on KRT had psychological morbidity, but only 17% reported their condition 
affected their mental health(2). Therefore, opportunities to identify and improve mental health may 
be being missed. Although some associated variables may be non-modifiable, their potential 
measurement in clinical practice might help identify those at higher risk of poor outcomes for close 
monitoring, greater psychosocial support, or targeted intervention. Compared to transplant, dialysis 
was associated with reduced QOL, wellbeing, disease acceptance, independence with activities of 
daily living, medication adherence, patient activation and patient satisfaction and a higher likelihood 
of psychological disturbance, worse body image and stigma. 
Our data furthers previous systematic evidence of lower QOL in young adults on dialysis compared 
to transplant(1) even after adjusting for a wide range of psychosocial variables, by identifying 
associated factors in a robust dataset. Our wellbeing model variables explained a high proportion of 
the variance. Young adults on dialysis have an increased mortality risk(16); our findings show dialysis 
is associated with lowered psychological as well as physical health. Our estimate of young adult low 
medication adherence mirrored that of adolescent non-adherence in a systematic review, at 43%(5). 
Although no clinical or psychosocial factors were associated with medication adherence in a 
previous study of transplanted young adults(17), we report many associations that are unlikely to be 
due to chance. Depression is known to lower adherence and be a major determinant of QOL in older 
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adults on KRT(18-20). Our study provides evidence that this is also true for young adults. Beliefs 
about medication were associated with adherence in a previous study of adults with kidney 
transplants(21); a similar effect may be seen in our data through conscientiousness and patient 
activation. 
Although the proportion with psychological morbidity is similar to the overall meta-analytical 
prevalence of depression in older adults with CKD [34.0% (95% CI 31.9, 36.2)](22), psychosocial 
health during young adulthood may have lasting life-course influences on developing adult identity 
and other outcomes(23). We found similar associations of extraversion, neuroticism and openness 
with mental wellbeing in young adults on KRT as previous studies of older adults with CKD(24) and 
kidney transplants(20). We have previously shown that compared to the general population, young 
adults are three times more likely to live in the family home(2) and whilst diminished independence 
could be considered undesirable, it had a positive association in our medication adherence model. 
Potential mechanisms underlying the psychosocial determinants of medication adherence include 
individual and environmental factors. Our data showed a lower age of finishing full-time education 
was associated with less adherence. This could be due to reduced health literacy. In a retrospective 
cohort study, half of young adults with CKD had limited health literacy skills, but health literacy was 
not associated with clinical outcomes(25). We found patient satisfaction was associated with higher 
adherence, suggesting that co-producing services with young adults could be valuable in engaging 
patients and improving healthcare utilization. Increasing patient activation was associated with 
higher adherence. In a longitudinal study, more activated patients were less likely to develop 
diabetes and diabetics were more likely to have better diabetic clinical indicators(26). Interventions 
that improve activation could have wider benefits than improving adherence alone. 
A range of psychosocial interventions have promise in improving outcomes, personality traits and 
adherence in chronic conditions, but evidence is lacking in KRT populations. Self-affirmation has 
been shown to improve phosphate and fluid management in adult hemodialysis patients(27, 28). A 
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systematic review of personality traits changes through intervention found marked differences over 
24 weeks in personality trait measures(29). Supportive evidence for interventions can also be found 
with other chronic conditions affecting young adults. There was modest evidence from a systematic 
review that psychological interventions improved glycemic control in children and adolescents with 
type 1 diabetes but not in adults(30). This suggests that we cannot assume interventions will be 
effective in young adults and require formal evaluations. Similarly, there is evidence from a 
systematic review that education, electronic trackers/reminders and simplified regimens result in 
better medication adherence amongst asthmatic patients than control interventions(31). 
Interventions can also positively influence social outcomes. Group cognitive behavioral therapy 
(CBT) has been shown to lower GHQ scores in the long-term unemployed, and compared to control 
programs increases the likelihood of finding full-time employment after 4 months(32). CBT could be 
a promising intervention in the improvement of wellbeing and medication adherence in young 
adults on KRT. 
Our study is strengthened by providing a comprehensive evaluation of aspects of psychological 
health in young adults on KRT, through utilization of established and widely-used scales. It is the 
largest cohort of young adult transplant and dialysis patients, with variation in modality and age at 
presentation. The study was multicenter, and our survey had a similar response rate to a large 
previous study of young adults with kidney transplants(33). By linking our survey data to a national 
kidney registry, we enhanced our self-reported data with clinical data. We reduced survey response 
bias by weighting our data, thereby improving generalizability to the wider young adult KRT 
population. 
Our study has several important limitations that need to be considered. The design is cross-
sectional, meaning the impact of treatment changes on the outcomes cannot be tracked and 
directionality between any of the variables cannot be established. For example, dialysis decisions 
may be influenced by poor social support/treatment engagement, comorbidities and prognosis 
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rather than being the cause of the observed negative associations. Longitudinal studies are needed 
to help determine the sequencing of events. Some kidney units were able to provide tablet devices 
to facilitate survey access (especially during dialysis) but this was not consistent. Self-reported 
outcomes may be prone to bias. We had missing data both from non-responders and non-
participants, though the use of anonymized UKRR allowed us to examine these differences. Although 
we adjusted for observed response bias, there may be residual unobserved bias due to limited 
comparisons with aggregate UKRR data for study non-participants. We did not conduct a mediation 
analysis, hence for those variables with potential mediators, total effects only were measured. We 
focused on medication adherence (an area of considerable interest for caregivers of young adults on 
KRT) although strong evidence that this is directly linked to graft loss is lacking. Our medication 
adherence model only explained a third of the observed variance in medication adherence scores. 
We found an interaction between dialysis and ethnicity so that Asian and Black patients on dialysis 
did worse in relation to medication adherence. This could relate to socio-cultural factors, but more 
work is required to understand these results. Pragmatically, it suggests these patients may require 
even greater clinical support. 
Future studies should enhance the understanding of our findings. In summary, this study 
demonstrates potentially modifiable associations with the important outcomes of wellbeing and 
medication adherence in young adult on KRT. This evidence base should form the basis for future 
research aimed at improving clinical and QOL outcomes. As psychological morbidity had a strong 
association with wellbeing and medication adherence, multidimensional interventions improving 
psychological health should be developed to improve outcomes.   
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Supplementary table 2. Psychological health in UK young adults receiving kidney replacement 
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Supplementary figure 1. Theoretical model of factors associated with quality of life in young adults 
receiving kidney replacement therapy. 
Directly measured variables are shaded blue and domains are unshaded. There may be 
bidirectionality between variables. 
Supplementary figure 2. Theoretical model of factors associated with medication adherence in 
young adults receiving kidney replacement therapy. 
Directly measured variables are shaded green and domains are unshaded. There may be 
bidirectionality between variables. 
 
Supplementary table 3. Coefficients and 95% confidence intervals for each variable in the wellbeing 
model in univariable analyses, for comparison to the mutually adjusted model shown in figure 2. 
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Supplementary table 4. Coefficients and 95% confidence intervals for each variable in the medication 
adherence model in univariable analyses, for comparison to the mutually adjusted model shown in 
figure 3.  
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TABLE 1. Clinical characteristics of survey responders. 
Variable 
Survey responders (n=625) 
n Proportion (%) 
Male sex 625 51 
Age, years (median, IQR) 625 25 (21, 28) 
Age group (16 to <21/21 to <26/26 to <31 years) 625 21, 30, 48 
Country 625   
England  74 
Scotland  6 
Wales  10 
Northern Ireland  10 
Ethnicity 625   
White   85 
Asian   9 
Black   4 
Other   3 
Index of multiple deprivation quintile 
(1 - least deprived/2/3/4/5 - most deprived)1 
625 19, 21, 17, 22, 21 
Managed in adult centre & aged <20 years 101 57 
Managed in transplant centre 625 55 
Nephrology unit size (small/medium/large)2 625 18, 46, 35 
Managed in Transition clinic centre3 625 64 
UK Renal Registry linked N=609 97% 
Duration since KRT start, years (median, IQR)4 609 6 (2, 11) 
Started in Adult unit 609 59 
Primary kidney disease5 572   
Glomerular diseases  27 
Systemic diseases affecting the kidney  7 
Familial/hereditary nephropathies  11 
Tubulointerstitial diseases  31 
Miscellaneous kidney disorders  18 
Time to KRT start from first nephrology review, days 
(median, IQR) 431 
745 (40, 1984) 
Time to KRT start for those in paediatric services 396 667 (34, 1923) 
Time to KRT start for those in adult services 35 1048 (211, 3441) 
Late referral 
(Time to KRT start <90 days/90 to <365 days/≥365 days) 
431 21, 9, 41 
Timeline data complete N=590 97% 
Starting modality  590   
Haemodialysis   37 
Peritoneal dialysis   39 
Transplant   21 
Starting transplant type  125  
 
Live donor   46 
Deceased donor   45 
Unknown   9 
Current modality 590   
Transplant   71 
Haemodialysis   24 
Peritoneal dialysis   6 
Current transplant type   417  
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Live donor   39 
Deceased donor   52 
Unknown   9 
Modality changes >90 days (0/1/≥2) 590 31, 38, 28 
Ever had a transplant 590 82 
Ever had a failed transplant 502 27 
Number of transplants (mean, SD) 502 1 (1) 
Biochemical variables 
Transplant (n=417) Dialysis (n=173) 
n Mean (SD) n Mean (SD) 
Estimated glomerular filtration rate, ml/min/1.73m2 414 59 (23) - - 
Chronic kidney disease stage (1/2/3a/3b/4/5) 
(Proportion, %) 
414 
10, 36, 26, 17, 
7, 2 
- - 
Haemoglobin, g/L 414 127 (18) 169 107 (17) 
Ferritin, µg/l (median, IQR) 350 135 (54, 308) 168 351 (211, 608) 
Bicarbonate, mmol/L 383 23 (3) 158 24 (4) 
Calcium, mmol/L 413 2.40 (0.12) 171 2.30 (0.22) 
Phosphate mmol/L 415 1.00 (0.26) 171 1.82 (0.64) 
Parathyroid hormone, pmol/L (median, IQR) 326 8.1 (5.0, 13.0) 157 
38.7 (18.5, 
86.1) 
Systolic blood pressure, mmHg 320 127 (14) 140 138 (25) 
Diastolic blood pressure, mmHg 305 77 (11) 137 84 (18) 
Weight, kg 303 68 (19) 137 71 (24) 
IQR - interquartile range, SD - standard deviation, KRT - kidney replacement therapy 
Participant interaction with the online survey that led to the generation of an identifiable survey record was counted as 
a response. Not all percentages may total 100 due to rounding. Where non-parametric, data are presented as median 
and interquartile range.  
1. We used derived UK-wide indexes of multiple deprivation quintiles(34) using postcodes. 
2. Defined by tertiles of prevalent KRT patients in 2015; we defined small units as having <500 adult patients/<50 
paediatric patients, medium units as having 500 to <1500 adult patients/50 to <100 paediatric patients, and large units 
as having ≥1500 adult patients/≥100 paediatric patients. 
3. As of September 2015(35), with additional data obtained directly from kidney units. 
4. If KRT start date was missing, the first timeline entry date was substituted. 
5. According to the 2012 European Renal Association-European Dialysis and Transplant Association coding system(13). 
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TABLE 2. Psychological health in UK young adults receiving kidney replacement therapy 
Scale 
Possible 
range 
N 
Weighted 
average score 
Weighted 
measure of 
variability 
Group 
Weighted 
proportion (%) 
   Median IQR   
EQ-5D-3L tariff -0.59, 1.00 538 0.80 0.62, 1.00   
General health questionnaire (GHQ-12) 0, 12 527 1 0, 5 Score 0 / 1-3 / ≥4 43, 26, 31 
Independence with activities of daily living scale 9, 27 545 26 21, 27   
Morisky medication adherence scale (MMAS-8)1 0, 8 543 6.5 4.75, 7 Low / Medium / High 43, 34, 23 
Body image scale 0, 30 520 9 3, 18   
Social impact scale 21, 96 467 40 28, 53   
Multidimensional scale of perceived social support 12, 84 499 65 54, 75   
Patient satisfaction questionnaire (PSQ-18)       
General Satisfaction 1, 5 500 4 3, 4.5   
Technical Quality 1, 5 499 4 3.5, 4.5   
Interpersonal Manner  1, 5 502 4 3.5, 5   
Communication 1, 5 503 4 3.5, 4.5   
Financial aspects 1, 5 499 4.5 3.5, 5   
Time Spent with Doctor 1, 5 501 4 3, 4   
Accessibility and Convenience 1, 5 500 3.75 3.25, 4.25   
   Mean SD   
Warwick-Edinburgh mental wellbeing scale 14, 70 535 47.4 11.5   
Acceptance of illness scale 8, 40 485 26.1 7.4 None / Moderate / Good 17, 49, 34 
Multidimensional health locus of control scale       
Internal 6, 36 486 22.2 5.3   
Chance 6, 36 483 20.3 5.1   
Powerful others 6, 36 484 21.7 5.0   
Big five inventory (BFI-44)       
Extraversion 1, 5 482 3.02 0.77   
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Agreeableness 1, 5 482 3.76 0.58   
Conscientiousness 1, 5 479 3.43 0.66   
Neuroticism 1, 5 481 3.12 0.85   
Openness 1, 5 480 3.40 0.56   
Patient activation measure (PAM-13) 0, 100 461 59.3 15.1 Level 1 / 2 / 3 / 4 26, 18, 36, 20 
Quality of life scale 16, 112 465 79.8 17.8     
CI - confidence interval; IQR - interquartile range; SD - standard deviation 
Total n=625. Data weighted by gender, ethnicity and index of multiple deprivation to be representative of prevalent UK young adults receiving KRT. Where non-parametric, data are presented 
as median and interquartile range. 
1. Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from Morisky Research LLC.  
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TABLE 3. Regression analyses of psychological health scales in UK young adults receiving kidney 
replacement therapy by current treatment 
Scale 
By modality (dialysis v. transplant), 
adjusted for age and sex 
β/OR 
95% CI 
p value 
Lower Upper 
 OR    
EQ-5D-3L tariff1 0.31 0.19 0.51 <0.001 
General health questionnaire (GHQ-12)2 1.90 1.22 2.96 0.005 
Morisky medication adherence scale (MMAS-8)3 0.40 0.25 0.64 <0.001 
Independence with activities of daily living scale 0.27 0.16 0.46 <0.001 
Body image scale 1.74 1.09 2.76 0.02 
Social impact scale 2.46 1.57 3.86 <0.001 
Multidimensional scale of perceived social support 0.90 0.61 1.34 0.61 
Patient satisfaction questionnaire (PSQ-18)     
General Satisfaction 0.55 0.38 0.80 0.002 
Technical Quality 0.53 0.33 0.85 0.01 
Interpersonal Manner  0.71 0.51 1.01 0.06 
Communication 0.58 0.40 0.84 0.004 
Financial aspects 0.88 0.54 1.41 0.59 
Time Spent with Doctor 0.39 0.22 0.68 0.001 
Accessibility and Convenience 0.52 0.37 0.75 0.001 
 β    
Warwick-Edinburgh mental wellbeing scale (WEMWBS) -5.61 -7.92 -3.29 <0.001 
Acceptance of illness scale -5.35 -6.78 -3.91 <0.001 
Multidimensional health locus of control scale     
Internal -1.16 -2.24 -0.08 0.04 
Chance 0.05 -1.04 1.13 0.93 
Powerful others -0.65 -1.81 0.51 0.29 
Big five inventory (BFI-44)     
Extraversion -0.09 -0.27 0.08 0.29 
Agreeableness -0.11 -0.21 -0.001 0.05 
Conscientiousness -0.20 -0.34 -0.05 0.01 
Neuroticism 0.21 0.05 0.37 0.01 
Openness -0.01 -0.11 0.10 0.90 
Patient activation measure (PAM-13) -4.52 -6.94 -2.10 <0.001 
Quality of life scale -6.79 -10.7 -2.85 0.001 
OR – Odds ratio; CI - confidence interval 
Data weighted by gender, ethnicity and index of multiple deprivation to be representative of prevalent UK young adults 
receiving KRT. Where non-parametric, scale scores are grouped into whether >50th centile or not for logistic regression 
analyses unless otherwise stated. For parametric data, beta coefficients represent the change in scale units (described in 
table 2). 
1. Grouped in logistic regression analyses as ‘No problems/’Some problems’ corresponding to a tariff of 1 or <1. 
2. Grouped in ordered regression analyses as 'No evidence of probable mental ill health'/'Less than optimal mental 
health'/'Probable psychological disturbance or mental ill health' corresponding to a scale score of 0, 1 to 3, or 4+.  
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3. Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is 
available from Morisky Research LLC. The MMAS-8 was grouped in ordered regression analyses as 
low/medium/high adherence corresponding to a scale score of <6, 6 to 7, or 8. 
LEGENDS TO FIGURES 
Figure 1. Study flowchart. 
Figure 2. Coefficient plot for mutually adjusted factors associated with wellbeing in young adults 
receiving kidney replacement therapy, measured by the Warwick-Edinburgh Mental Wellbeing 
Scale. 
ADLs – activities of daily living 
N=401. Higher scores indicate greater mental wellbeing. The beta coefficient of the model intercept 
was 57.4 (95% confidence interval 50.9, 63.8), p<0.001. The model adjusted R2 was 0.68. For 
personality scales, the coefficient is for each 1-unit scale change. ‘Negative body image’ is for each 
10-unit change on the Body Image Scale. ‘Greater social impact’ is for each 20-unit change on the 
Social Impact Scale. Psychological disturbance was defined by a GHQ-12 score of 4 or more. When 
the GHQ-12 was omitted from the model the adjusted R2 was 0.62, indicating it does not explain a 
large proportion of the variance.  
 
Figure 3. Coefficient plot for mutually adjusted factors associated with medication adherence in 
young adults receiving kidney replacement therapy, measured using the 8-item Morisky 
Medication Adherence Scale. 
N=432. Higher scores indicate a greater degree of medication adherence. The beta coefficient of the 
model intercept was 3.13 (95% confidence interval (CI) 1.78, 4.48), p<0.001. The model adjusted R2 
was 0.33. For personality and patient satisfaction scales, the coefficient is for each 1-unit scale 
change. Psychological disturbance was defined by a GHQ-12 score of 4 or more. 
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